ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,462Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 917

$790K Total Retail Price of All Prescriptions

Rank: 31 out of 917

640 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 640 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 640 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,972 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
HYDROCODONE-ACETAMINOPHEN 494 347 S3 1 6
LISINOPRIL 436 378 2 1
OMEPRAZOLE 419 329 3 4
LEVOTHYROXINE SODIUM 342 300 4 3
SIMVASTATIN 341 312 5 2
METFORMIN HCL 280 240 6 8
AMLODIPINE BESYLATE 269 246 7 5
ZOLPIDEM TARTRATE 236 181 8 21
METOPROLOL TARTRATE 221 210 9 11
HYDROCHLOROTHIAZIDE 207 190 10 9
GABAPENTIN 192 129 11 17
LOSARTAN POTASSIUM 175 165 12 13
FUROSEMIDE 174 158 13 7
ATORVASTATIN CALCIUM 174 170 13 14
METOPROLOL SUCCINATE 172 148 15 18
POTASSIUM CHLORIDE 160 141 16 16
LOVASTATIN 156 131 17 19
OXYCODONE HCL 147 37 S2 18 27
FLUTICASONE PROPIONATE 144 138 19 26
NAPROXEN 141 91 20 107
NAMENDA 141 141 20 43
CARVEDILOL 135 117 22 33
WARFARIN SODIUM 124 117 23 10
GLIPIZIDE 124 117 23 40
PRAVASTATIN SODIUM 124 109 23 20
SERTRALINE HCL 123 109 26 24
TRAMADOL HCL 113 99 27 28
ATENOLOL 111 94 28 12
ALLOPURINOL 111 108 28 31
CRESTOR 99 90 30 30
RANITIDINE HCL 95 64 31 29
PANTOPRAZOLE SODIUM 95 64 31 44
TRAZODONE HCL 94 79 33 22
AZITHROMYCIN 91 80 34 61
TAMSULOSIN HCL 91 91 34 25
CYCLOBENZAPRINE HCL 90 40 R 36 65
CYMBALTA 88 22 37 56
DONEPEZIL HCL 87 87 38 32
AMITRIPTYLINE HCL 86 75 R 39 67
CIPROFLOXACIN HCL 81 71 40 72
NEXIUM 79 76 41 60
JANUVIA 75 75 42 81
SPIRONOLACTONE 75 67 42 55
CITALOPRAM HBR 72 52 44 15
SPIRIVA 71 40 45 45
MORPHINE SULFATE ER 70 0 S2 46 48
FLUOXETINE HCL 70 58 46 38
DIOVAN 70 70 46 49
BACLOFEN 69 0 49 82
LANTUS 68 49 50 37
OXYCODONE-ACETAMINOPHEN 68 22 S2 50 46
PEN NEEDLE 66 61 52 99
LANTUS SOLOSTAR 66 53 52 63
FINASTERIDE 66 63 52 77
DILTIAZEM 24HR CD 64 63 55 95
DIGOXIN 63 63 56 41
METHADONE HCL 63 0 S2 56 59
DOXAZOSIN MESYLATE 62 60 58 74
SYNTHROID 62 49 58 68
PROAIR HFA 60 31 60 35
CLOPIDOGREL 59 54 61 50
PREDNISONE 59 44 61 34
GLYBURIDE 57 57 R 63 71
MELOXICAM 56 51 64 53
PAROXETINE HCL 53 31 65 57
DOXYCYCLINE HYCLATE 51 37 66 169
TERAZOSIN HCL 50 48 67 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.